Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

RecruitingPhase 4

ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* Participants must agree to follow the reproductive criteria as outlined in the protocol
* Participants have completed a qualifying Parent Study, were still receiving elranatamab when the Parent Study terminated or completed, and are deriving clinical benefit from elranatamab (as determined by the investigator).

Exclusion Criteria:

* Any medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
* Participants not previously enrolled or who have discontinued study treatment in a Parent Study are ineligible for participation in this study.

About the study

This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.

What is being tested

Elranatamab (drug)

Sponsor: Pfizer · Participants: 80 · Started: Oct 3, 2023

Contact the study team

Pfizer CT.gov Call Center · Phone: 1-800-718-1021

Official record on ClinicalTrials.gov — NCT06057402

Locations in the U.S.

California	UCI Health - Irvine Infusion Pharmacy ACC, Irvine UC Irvine Health, Orange UCI Health, Orange
Colorado	UCHealth Harmony, Fort Collins UCHealth Poudre Valley Hospital, Fort Collins UCHealth Greeley Hospital, Greeley Longs Peak Hospital, Longmont UCHealth Longs Peak Medical Center, Longmont UCHealth - Medical Center of the Rockies, Loveland
Florida	Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables University of Miami Hospital and Clinics Deerfield Beach, Deerfield Beach Sylvester Comprehensive Cancer Center, Miami University of Miami Hospital and Clinics, Miami University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
Michigan	University of Michigan, Ann Arbor Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
Texas	St. David's South Austin Medical Center, Austin

Conditions

Multiple Myeloma

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.